Helicobacter Pylori Infection and Atherosclerosis: a Systematic Review
,
Abstract
Helicobacter pylori (H. pylori) is a spiral-shaped gram negative bacterium that naturally colonizes the human gastric epithelium. In recent years, large evidence has come to the literature strongly proposing causal link between H. pylori and extra gastric disorders. Cardiovascular system is one of the extra gastric organs that can be affected by H. pylori infection. The first evidence suggestive of such an association comes from seroepidemiological evaluations, but histopathological and eradication studies have strongly confirmed existence of a causal association between H. pylori infection and cardiovascular events.
Gray BM, Fontaine CA, Poe SA, et al. Complex T cell interactions contribute to Helicobacter pylori gastritis in mice. Infect Immun 2013;81(3):740-52.
Zhang Y, Weck MN, Schöttker B, et al. Gastric Parietal Cell Antibodies, Helicobacter Pylori Infection, and Chronic Atrophic Gastritis: Evidence from a Large Population-based Study in Germany. Cancer Epidemiol Biomarkers Prev 2013;22(5):821-6.
Zhou X, Zhang C, Wu J, et al. Association between Helicobacter pylori infection and diabetes mellitus: A meta-analysis of observational studies. Diabetes Res Clin Pract 2013;99(2):200-8.
Wang ZW, Li Y, Huang LY, et al. Helicobacter pylori infection contributes to high risk of ischemic stroke: evidence from a meta-analysis. J Neurol 2012;259(12):2527-37.
Roubaud Baudron C, Letenneur L, Langlais A, et al. Personnes Agées QUID Study. Does Helicobacter pylori infection increase incidence of dementia? The Personnes Agées QUID Study. J Am Geriatr Soc 2013;61(1):74-8.
Shaban MM, Kandil HO, Elshafei AH. Helicobacter Pylori Seropositivity in Patients with Hyperemesis Gravidarum. Am J Med Sci 2014;347(2):101-5.
Franceschi F, Di Simone N, D'Ippolito S, et al. Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia? Helicobacter 2012;17(6):426-34.
Ambrosini G, Andrisani A, Fiore C, et al. Anti- Helicobacter pylori antibodies in cervical mucus: a new cause of infertility. Eur J Obstet Gynecol Reprod Biol 2011;155(2):157-60.
Bagnis A, Izzotti A, Saccà SC. Helicobacter pylori, oxidative stress and glaucoma. Dig Liver Dis 2012;44(11):963-4.
Magen E, Mishal J. Possible benefit from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria. Clin Exp Dermatol 2013;38(1):7-12.
Campuzano-Maya G. Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol 2011;17(26):3165-70.
Cakmak SK, Cakmak A, Gül U, et al. Upper gastrointestinal abnormalities and Helicobacter pylori in Behçet's disease. Int J Dermatol. 2009;48(11):1174-6.
Izadi F, Ahmadi A, Ghourchian S, et al. Detection of helicobacter pylori in benign laryngeal lesions by polymerase chain reaction: a cross sectional study. Infect Agent Cancer 2012;7(1):10.
Gong H, Shi Y, Zhou L, et al. Helicobacter pylori infection of the larynx may be an emerging risk factor for laryngeal squamous cell carcinoma. Clin Transl Oncol 2012;14(12):905-10.
Deng B, Li Y, Zhang Y, et al. Helicobacter Pylori Infection and Lung Cancer: A Review of an Emerging Hypothesis. Carcinogenesis 2013;34(6):1189-95.
Papagiannakis P, Michalopoulos C, Papalexi F, et al. The role of Helicobacter pylori infection in hematological disorders. Eur J Intern Med 2013;24(8):685-90.
Payandeh M, Sohrabi N, Zare ME, et al. Platelet Count Response to Helicobacter pylori Eradication in Iranian Patients with Idiopathic Thrombocytopenic Purpura. Mediterr J Hematol Infect Dis 2012;4(1):e2012056.
Pirouz T, Zounubi L, Keivani H, et al. Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method. Dig Dis Sci 2009;54(7):1456-9.
Pellicano R, Ménard A, Rizzetto M, et al. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008;8(4):254-60.
Chen Y, Segers S, Blaser MJ. Association between Helicobacter pylori and mortality in the NHANES III study. Gut 2013;62(9):1262-9.
Schöttker B, Adamu MA, Weck MN, et al. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis. 2012;220(2):569-74.
Izadi M, Fazel M, Sharubandi SH, et al. Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease. Cardiovasc Pathol 2012;21(4):307-11.
Amini M, Karbasi A, Khedmat H, et al. Helicobacter pylori eradication and histopathological esophagitis in dyspeptic patients. Trop Gastroenterol 2010;31(3):175-9.
Longo-Mbenza B, Nsenga JN, Mokondjimobe E, et al. Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans. Vasc Health Risk Manag. 2012;6:455-61.
Eskandarian R, Ghorbani R, Shiyasi M, et al. Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study. Cardiovasc J Afr 2012;23(3):131-5.
Kountouras J, Gavalas E, Boziki M, et al. Helicobacter pylori may be involved in cognitive impairment and dementia development through induction of atrophic gastritis, vitamin B-12 folate deficiency, and hyperhomocysteinemia sequence. Am J Clin Nutr 2007;86(3):805-6.
Kamada T, Hata J, Kusunoki H, et al. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis 2005;37(1):39-43.
Park MJ, Choi SH, Kim D, et al. Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population. Gut Liver 2011;5(3):321-7.
Al-Ghamdi A, Jiman-Fatani AA, El-Banna H. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease. Pak J Pharm Sci 2011;24(2):95-101.
Arabski M, Konieczna I, Sołowiej D, et al. Are anti-Helicobacter pylori urease antibodies involved in atherosclerotic diseases? Clin Biochem 2010;43(1-2):115-23.
Torisu T, Takata Y, Ansai T, et al. Possible association of atrophic gastritis and arterial stiffness in healthy middleaged Japanese. J Atheroscler Thromb 2009;16(5):691-7.
Jha HC, Prasad J, Mittal A. High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity Creactive protein in coronary artery disease patients in India can serve as atherosclerotic marker. Heart Vessels 2008;23(6):390-6.
Tamer GS, Tengiz I, Ercan E, et al. Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig Dis Sci 2009;54(6):1253-6.
Sawayama Y, Hamada M, Otaguro S, et al. Chronic Helicobacter pylori infection is associated with peripheral arterial disease. J Infect Chemother 2008;14(3):250-4.
Nikolopoulou A, Tousoulis D, Antoniades C, et al. Common community infections and the risk for coronary artery disease and acute myocardial infarction: evidence, for chronic over-expression of tumor necrosis factor alpha and vascular cells adhesion molecule-1. Int J Cardiol 2008;130(2):246-50.
Ozdogru I, Kalay N, Dogan A, et al. The relationship between Helicobacter pylori IgG titre and coronary atherosclerosis. Acta Cardiol 2007;62(5):501-5.
Folsom AR, Nieto FJ, Sorlie P, et al. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation 1998;98(9):845-50.
Regnström J, Jovinge S, Båvenholm P, et al. Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. J Intern Med 1998;243(2):109-13.
Ossewaarde JM, Feskens EJ, De Vries A, et al. Chlamydiapneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998;120(1):93-9.
Yoshikawa H, Aida K, Mori A, et al. Involvement of Helicobacter pylori infection and impaired glucose metabolism in the increase of brachial-ankle pulse wave velocity. Helicobacter 2007;12(5):559-66.
Goyal P, Kalek SC, Chaudhry R, et al. Association of common chronic infections with coronary artery disease in patients without any conventional risk factors. Indian J Med Res. 2007;125(2):129-36.
Altannavch Ts, Roubalová K, Broz J, et al. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris. Cent Eur J Public Health 2003;11(2):102-6.
Lentine KL, Parsonnet J, Taylor I, et al. Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Clin Exp Nephrol 2006;10(1):55-62.
Saijo Y, Utsugi M, Yoshioka E, et al. Relationship of Helicobacter pylori infection to arterial stiffness in Japanese subjects. Hypertens Res 2005;28(4):283-92.
Ongey M, Brenner H, Thefeld W, et al. Helicobacter pylori and hepatitis A virus infections and the cardiovascular riskprofile in patients with diabetes mellitus: results of a population-based study. Eur J Cardiovasc Prev Rehabil 2004;11(6):471-6.
Cassar K, Bachoo P, Ford I, et al. Helicobacter pylori seropositivity is associated with enhanced platelet activation in patients with intermittent claudication. J Vasc Surg 2004;39(3):560-4.
Bloemenkamp DG, Mali WP, Tanis BC, et al. Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women. Atherosclerosis 2002;163(1):149-56.
Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al; AtheroGene Investigators. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002;105(1):15-21.
Kahan T, Lundman P, Olsson G, et al. Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction. Coron Artery Dis 2000;11(7):523-6.
Jia EZ, Zhao FJ, Hao B, et al. Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis 2009;8(1):59.
Coskun S, Kasirga E, Yilmaz O, et al. Is Helicobacter pylori related to endothelial dysfunction during childhood? Pediatr Int 2008;50(2):150-3.
Khairy P, Rinfret S, Tardif JC, et al. Absence of association between infectious agents and endothelial function in healthy young men. Circulation 2003;107(15):1966-71.
Grabczewska Z, Nartowicz E, Szymaniak L, et al. Endothelial dysfunction in acute coronary syndrome without ST segment elevation in the presence of Helicobacter pylori infection. Kardiol Pol 2002;57(12):533-4.
Prasad A, Zhu J, Halcox JP, et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002;106(2):184-90.
Liuba P, Pesonen E, Paakkari I, et al. Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular endothelial dysfunction and enhanced VCAM-1 expression in apoE-knockout mice. J Vasc Res 2003;40(2):115-22.
Xu Q, Schett G, Perschinka H, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000;102(1):14-20.
Schett G, Xu Q, Amberger A, et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995;96(6):2569-77.
Birnie DH, Holme ER, McKay IC, et al. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998;19(3):387-94.
Okada T, Ayada K, Usui S, et al. Antibodies against heat shock protein 60 derived from Helicobacter pylori: diagnostic implications in cardiovascular disease. J Autoimmun 2007;29(2-3):106-15.
Prohászka Z, Duba J, Horváth L, et al. Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest 2001;31(4):285-92.
Lenzi C, Palazzuoli A, Giordano N, et al. H. pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease. World J Gastroenterol 2006;12(48):7815-20.
Wu Y, Tao Z, Song C, et al. Overexpression of YKL-40 Predicts Plaque Instability in Carotid Atherosclerosis with CagA-Positive Helicobacter Pylori Infection. PLoS One. 2013;8(4):e59996.
Nazligul Y, Aslan M, Horoz M, et al. The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected. Clin Biochem 2011;44(8-9):647-9.
Kebapcilar L, Sari I, Renkal AH, et al. The influence of Helicobacter pylori eradication on leptin, soluble CD40 ligand, oxidative stress and body composition in patients with peptic ulcer disease. Intern Med 2009;48(24):2055-9.
Aydemir S, Eren H, Tekin IO, et al. Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels. Mediators Inflamm 2010;2010:685903.
Kanbay M, Gür G, Yücel M, et al. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 2005;50(7):1228-31.
Migneco A, Ojetti V, Specchia L, et al. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter 2003;8(6):585-9.
Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 2001;52(1 Suppl 1):3-31.
Blum A, Tamir S, Mualem K, et al. Endothelial dysfunction is reversible in Helicobacter pylori-positive subjects. Am J Med 2011;124(12):1171-4.
Schweeger I, Fitscha P, Sinzinger H. Successful eradication of Helicobacter pylori as determined by ((13)) C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res 2000;97(6):411-20.
Jha HC, Srivastava P, Divya A, et al. Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients. APMIS. 2009;117(12):905-11.
Ciervo A, Mancini F, Sale P, et al. Real-time polymerase chain reaction and laser capture microdissection: an efficient combination tool for Chlamydophila pneumoniae DNA quantification and localization of infection in atherosclerotic lesions. Int J Immunopathol Pharmacol 2008;21(2):421-8.
Hagiwara N, Toyoda K, Inoue T, et al. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients. J Stroke Cerebrovasc Dis 2007;16(4):145-52.
Latsios G, Saetta A, Michalopoulos NV, et al. Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by the polymerase chain reaction. Acta Cardiol 2004;59(6):652-7.
Dore MP, Sepulveda AR, Bacciu PP, et al. Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Dig Dis Sci 2003;48(5):945-51.
Kaklikkaya I, Kaklikkaya N, Buruk K, et al. Investigation of Chlamydia pneumoniae DNA, chlamydial lipopolisaccharide antigens, and Helicobacter pylori DNA in atherosclerotic plaques of patients with aortoiliac occlusive disease. Cardiovasc Pathol 2006;15(2):105-9.
Kilic A, Onguru O, Tugcu H, et al. Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR. Pol J Microbiol 2006;55(4):333-7.
Kaplan M, Yavuz SS, Cinar B, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 2006;10(2):116-23.
Sulewska A, Modrzejewski W, Kovalchuk O, et al. Attempts to detect Helicobacter pylori in atherosclerotic plaques. Rocz Akad Med Bialymst 2004;49 (Suppl 1):239-41.
Rassu M, Cazzavillan S, Scagnelli M, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis 2001;158(1):73-9.
Farsak B, Yildirir A, Akyön Y, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000;38(12):4408-11.
Blasi F, Denti F, Erba M, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996;34(11):2766-9.
Khedmat H, Karami A, Safiri Z, et al. Diagnostic accuracy of PCR based method using four gene primers to detect Helicobacter pylori infection in gastric tissues: report from Iran. Trop Gastroenterol 2010;31(2):116-8.
Mayr M, Kiechl S, Tsimikas S, et al. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study. J Am Coll Cardiol 2006;47(12):2436-43.
Khedmat H, Karami A, Safiri Z, et al. Helicobacter pylori genotypes can predict gastric tissue histopathology: a longitudinal study of Iranian patients. J Infect Public Health 2012;5(2):153-8.
Huang B, Chen Y, Xie Q, et al. CagA-positiveHelicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease. Dig Dis Sci 2011;56(1):109-14.
Niccoli G, Franceschi F, Cosentino N, et al. Coronary atherosclerotic burden in patients with infection by CagApositive strains of Helicobacter pylori. Coron Artery Dis 2010;21(4):217-21.
Franceschi F, Niccoli G, Ferrante G, et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009;202(2):535-42.
Zhang S, Guo Y, Ma Y, et al. Cytotoxin-associated gene- A-seropositive virulent strains of Helicobacter pylori and atherosclerotic diseases: a systematic review. Chin Med J (Engl) 2008;121(10):946-51.
Chimienti G, Russo F, Lamanuzzi BL, et al. Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein (a). Clin Biochem 2003;36(5):359-65.
Chmiela M, Kowalewicz-Kulbat M, Miszczak A, et al. A link between Helicobacter pylori and/or Chlamydia spp. infections and atherosclerosis. FEMS Immunol Med Microbiol 2003;36(3):187-92.
Murray LJ, Bamford KB, Kee F, et al. Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a populationbased case-control study of myocardial infarction. Atherosclerosis 2000;149(2):379-85.
Schimke K, Chubb SA, Davis WA, et al. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis 2010;212(1):321-6.
Rožanković PB, Huzjan AL, Cupić H, et al. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease. J Neurol. 2011;258(5):753-61.
Diomedi M, Stanzione P, Sallustio F, et al. Cytotoxinassociated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke. Helicobacter 2008;13(6):525-31.
Mayr M, Kiechl S, Mendall MA, et al. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003;34(3):610-5.
Pietroiusti A, Diomedi M, Silvestrini M, et al. Cytotoxinassociated gene-A--positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002;106(5):580-4.
Markus HS, Risley P, Mendall MA, et al. Helicobacter pylori infection, the cytotoxin gene A strain, and carotid artery intima-media thickness. J Cardiovasc Risk 2002;9(1):1-6.
Shmuely H, Passaro DJ, Vaturi M, et al. Association of CagA+ Helicobacter pylori infection with aortic atheroma. Atherosclerosis 2005;179(1):127-32.
Nyberg A, Skagius E, Nilsson I, et al. Abdominal aortic aneurysm and infection with CagA positive strains of Helicobacter pylori. Scand J Infect Dis 2008;40(3):204-7.
Ziver T, Yuksel P, Ipek G, et al. Aneurysm and Helicobacter pylori relationship: the seropositivity of CagA, VacA and other antigens of Helicobacter pylori in abdominal and ascending aortic aneurysms. New Microbiol 2010;33(3):233-42.
Kim HL, Jeon HH, Park IY, et al. Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans. J Korean Med Sci. 2011;26(5):654-8.
Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 2007;121(3):229-38.
Sung KC, Rhee EJ, Ryu SH, et al. Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol 2005;102(3):411-7.
Laurila A, Bloigu A, Näyhä S, et al. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999;142(1):207-10.
Kucukazman M, Yavuz B, Sacikara M, et al. The relationship between updated Sydney System score and LDL cholesterol levels in patients infected with Helicobacter pylori. Dig Dis Sci 2009;54(3):604-7.
Akbas HS, Basyigit S, Suleymanlar I, et al. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects. Lipids Health Dis 2010;9(1):92.
Itou S, Goto Y, Kondo T, et al. No associations of Helicobacter pylori infection and gastric atrophy with plasma total homocysteine in Japanese. Int J Med Sci 2007;4(2):98-104.
Adiloglu AK, Can R, Kinay O, et al. Infection with Chlamydia pneumoniae but not Helicobacter pylori is related to elevated apolipoprotein B levels. Acta Cardiol 2005;60(6):599-604.
| Files | ||
| Issue | Vol 53, No 2 (2015) | |
| Section | Original Article(s) | |
| Keywords | ||
| Helicobacter pylori Infection Atherosclerosis Systematic Review | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
